FindTrial
Sign In

IgPro10

BIOLOGICAL5 trials

Sponsors

CSL Behring

Conditions

Chronic Inflammatory Demyelinating PolyneuropathyDiffuse Cutaneous Systemic SclerosisImmune Thrombocytopenic PurpuraPediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Polyradiculoneuropathy

Phase 2

Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)
CompletedNCT04137224
CSL BehringDiffuse Cutaneous Systemic Sclerosis
Start: 2019-09-19End: 2022-05-17Updated: 2024-02-05
Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)
WithdrawnNCT04138485
CSL BehringDiffuse Cutaneous Systemic Sclerosis
Start: 2019-12-20End: 2020-09-16Updated: 2020-11-17

Phase 3

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)
CompletedNCT01545076
CSL BehringChronic Inflammatory Demyelinating Polyneuropathy, Polyradiculoneuropathy
Start: 2012-03-31End: 2016-09-30Updated: 2018-07-05

Phase 4

A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP)
CompletedNCT01390649
CSL BehringImmune Thrombocytopenic Purpura
Start: 2011-11-30End: 2014-09-30Updated: 2016-04-08
Two Dose Levels of Privigen in Pediatric CIDP
RecruitingNCT03684018
CSL BehringPediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Start: 2019-02-28End: 2029-12-20Target: 30Updated: 2026-06-01

Related Papers

A phase 2 randomized trial of safety and pharmacokinetics of IgPro20 and IgPro10 in patients with diffuse cutaneous systemic sclerosis
Lara D. Veeken2025-01-31
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
Journal of the Peripheral Nervous System2019-01-2429 citations
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial.
2017-11-06185 citations
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial
Trials2016-07-2524 citations
Use of immunoglobulin (Ig) in peripheral neuropathies. Impact of Ig on remission rates: comparison of intravenous immunoglobulin and subcutaneous immunoglobulin
Clinical & Experimental Immunology2014-12-01